Sleeping hearts: The role of the heart in sleeping sickness (human African trypanosomiasis)

Tropical Medicine and International Health

Volumn 12, Issue 12, 2007, Pages 1422-1432

  Blum, Johannes A ^a   Burri, Christian ^a   Hatz, Christoph ^a   Kazumba, Leon ^b   Mangoni, Patrick ^c   Zellweger, Michael J ^d  

^a SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^b Centre Neuro Psycho Pathologique   (Democratic Republic Congo)

^c Hôpital Evangélique de Vanga   (Democratic Republic Congo)

^d UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Brain natriuretic peptide; Cardiopathy; ECG findings; Human African trypanosomiasis; Troponin

Indexed keywords

EFLORNITHINE; MELARSOPROL; PROMETHAZINE;

CARDIOVASCULAR SYSTEM; COHORT ANALYSIS; DISEASE TREATMENT; ELECTRONIC EQUIPMENT; PEPTIDE; PROTEIN; SLEEP; SYMPTOM; TRYPANOSOMIASIS;

ADULT; AFRICAN TRYPANOSOMIASIS; ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DYSPNEA; ELECTROCARDIOGRAM; FOLLOW UP; HEART PALPITATION; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; PROSPECTIVE STUDY;

ADULT; ANIMALS; EFLORNITHINE; ELECTROCARDIOGRAPHY; FEMALE; HEART DISEASES; HUMANS; MALE; MELARSOPROL; TRYPANOCIDAL AGENTS; TRYPANOSOMA BRUCEI GAMBIENSE; TRYPANOSOMIASIS, AFRICAN;

EID: 36749044322     PISSN: 13602276     EISSN: 13653156     Source Type: Journal    
DOI: 10.1111/j.1365-3156.2007.01948.x     Document Type: Article

References (33)

1. Adams JH, Haller L, Boa FY et al. (1986) Human African trypanosomiasis (T.b. gambiense): a study of 16 fatal cases of sleeping sickness with some observations on acute reactive arsenical encephalopathy. Neuropathology and Applied Neurobiology 12, 81 94.
2. Al Khatib SM, LaPointe NM, Kramer JM Califf RM (2003) What clinicians should know about the QT interval. JAMA 289, 2120 2127.
3. Bay M, Kirk V, Parner J et al. (2003) NT-proBNP: a new diagnostic screening tool to differentiate between patients with normal and reduced left ventricular systolic function. Heart 89, 150 154.
4. Bertrand E, Sentilhes L, Baudin L, Barabe P Aye H (1969) Conduction disorders in African human trypanosomiasis caused by Trypanosoma gambiense. Archives des Maladies du Coeur et des Vaisseaux 62, 247 253.
5. Bertrand E, Serie F, Kone I et al. (1973a) Symptomatologie générale de la trypanosomiase humaine africaine au moment du dépistage. Médecine d'Afrique Noire 20, 303 314.
6. Bertrand E, Serie F, Rive J et al. (1973b) La symptomatologie cardio-vasculaire dans la trypanosomiase humaine africaine à Trypanosoma gambiense. Médecine d'Afrique Noire 20, 327 339.
7. Bertrand E, Serie F, Rive J et al. (1974) Current aspects of the cardiac symptoms in African human trypanosomiasis due to Trypanosoma gambiense (apropos of 194 cases). Acta Cardiologica 29, 363 381.
8. Blum J, Nkunku S Burri C (2001) Clinical description of encephalopathic syndromes and risk factors for their occurrence and outcome during melarsoprol treatment of human African trypanosomiasis. Tropical Medicine & International Health 6, 390 400.
9. Blum J, Schmid C Burri C (2006) Clinical aspects of 2541 patients with second stage human African trypanosomiasis. Acta Tropica 97, 55 64.
10. Collomb H Bartoli D (1967) The heart in human African trypanosomiasis caused by Trypanosoma gambiense. Bulletin de la Société de Pathologie Exotique et de ses Filiales 60, 142 156.
11. Costello-Boerrigter LC, Boerrigter G, Redfield MM et al. (2006) Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the general community: determinants and detection of left ventricular dysfunction. Journal of the American College of Cardiology 47, 345 353.
12. Dupont B, Charmot G Lapresle C (1979) Trypanosomiasis presenting with trypanids and complicated by myopericarditis (author's transl). La Nouvelle Presse Médicale 8, 1579 1581.
13. Fouchet M Gateff C (1968) Development of cardiovascular involvement in African trypanosomiasis due to Trypanosoma gambiense. Médecine Tropicale: Revue du Corps de Santé Colonial 28, 583 590.
14. Koten JW De RaadtP (1969) Myocarditis in Trypanosoma rhodesiense infections. Transactions of the Royal Society of Tropical Medicine and Hygiene 63, 485 489.
15. Morrison WI, Murray M, Sayer PD Preston JM (1981) The pathogenesis of experimentally induced Trypanosoma brucei infection in the dog. I. Tissue and organ damage. The American Journal of Pathology 102, 168 181.
16. Moss AJ (1993) Measurement of the QT interval and the risk associated with QTc interval prolongation: a review. The American Journal of Cardiology 72, 23B 25B.
17. Pepin J, Milord F, Khonde AN et al. (1995) Risk factors for encephalopathy and mortality during melarsoprol treatment of Trypanosoma brucei gambiense sleeping sickness. Transactions of the Royal Society of Tropical Medicine and Hygiene 89, 92 97.
18. Poltera AA (1980) Immunopathological and chemotherapeutic studies in experimental trypanosomiasis with special reference to the heart and brain. Transactions of the Royal Society of Tropical Medicine and Hygiene 74, 706 715.
19. Poltera AA Sayer PD (1983) Cardiac lymph drainage in experimental African trypanosomiasis in vervet monkeys. Bulletin de la Société de Pathologie Exotique et de ses Filiales 76, 614 621.
20. Poltera AA, Cox JN Owor R (1976) Pancarditis affecting the conducting system and all valves in human African trypanosomiasis. British Hzeart Journal 38, 827 837.
21. Poltera AA, Hochmann A Lambert PH (1980) A model for cardiopathy induced by Trypanosoma brucei brucei in mice. A histologic and immunopathologic study. The American Journal of Pathology 99, 325 351.
22. Poltera AA, Hochmann A Lambert PH (1981) Trypanosoma brucei brucei: the response to Melarsoprol in mice with cerebral trypanosomiasis. An immunopathological study. Clinical and Experimental Immunology 46, 363 374.
23. Poltera AA, Sayer PD, Brighouse G, Bovell D Rudin W (1985a) Immunopathological aspects of trypanosomal meningoencephalitis in vervet monkeys after relapse following Berenil treatment. Transactions of the Royal Society of Tropical Medicine and Hygiene 79, 527 531.
24. Poltera AA, Sayer PD, Rudin W Bovell D (1985b) Trypanosomal cardiac valvulitis in vervet monkeys. Tropical Medicine and Parasitology 36, 77 80.
25. Ribeiro AL, Teixeira MM, Reis AM et al. (2006) Brain natriuretic peptide based strategy to detect left ventricular dysfunction in Chagas disease: a comparison with the conventional approach. International Journal of Cardiology 109, 34 40.
26. Robertson D Knight R (1964) Observations on the polyneuropathy and the disordered pyruvate metabolism by nitrofurazone in cases of sleeping sickness due to Trypanosoma thodesiense. Acta Tropica 21, 239 263.
27. Roongsritong C, Warraich I Bradley C (2004) Common causes of troponin elevations in the absence of acute myocardial infarction: incidence and clinical significance. Chest 125, 1877 1884.
28. Schyns C Janssen P (1955) Electrocardiographic findings in sleeping sickness. Acta Cardiologica 10, 266 278.
29. Tsala MP, Blackett K, Mbonifor CL, Leke R Etoundi J (1988) Functional and immunologic involvement in human African trypanosomiasis caused by Trypanosoma gambiense. Bulletin de la Société de Pathologie Exotique et de ses Filiales 81, 490 501.
30. Wang K, Asinger RW Marriott HJ (2003) ST-segment elevation in conditions other than acute myocardial infarction. New England Journal of Medicine 349, 2128 2135.
31. WHO (1988) Control and Surveillance of African Trypanosomiasis. WHO, Geneva.
32. WHO (2003) Report on the Scientific Working Group Meeting on African Trypanosomiasis, Geneva, 4-8 June, 2001. WHO, Geneva.
33. WHO (2006) Human African Trypanosomiais (sleeping sickness): epidemiological update. Weekly Epidemiological Record 8, 71 80.